1. Home
  2. ITP vs MBIO Comparison

ITP vs MBIO Comparison

Compare ITP & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IT Tech Packaging Inc.

ITP

IT Tech Packaging Inc.

HOLD

Current Price

$0.23

Market Cap

4.0M

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$1.01

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITP
MBIO
Founded
1996
2015
Country
China
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ITP
MBIO
Price
$0.23
$1.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
140.8K
72.4K
Earning Date
11-13-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$78,936,065.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.89
52 Week High
$1.00
$7.00

Technical Indicators

Market Signals
Indicator
ITP
MBIO
Relative Strength Index (RSI) 47.58 39.25
Support Level $0.22 $1.07
Resistance Level $0.24 $1.20
Average True Range (ATR) 0.01 0.06
MACD -0.00 0.00
Stochastic Oscillator 55.06 29.63

Price Performance

Historical Comparison
ITP
MBIO

About ITP IT Tech Packaging Inc.

IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: